GoodRx Holdings, Inc. (GDRX) Tops Q1 EPS by 1c; Offers Guidance

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q1 EPS of $0.07, $0.01 better than the analyst estimate of $0.06. Revenue for the quarter came in at $184 million versus the consensus estimate of $182.07 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q2 2023 revenue of $185-188 million, versus the consensus of $191.7 million.

GoodRx Holdings, Inc. sees FY2023 revenue of $750-775 million, versus the consensus of $784 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch
• Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'